Android app on Google Play

Lexicon Pharmaceuticals (LXRX) Reports In-Line Q4 EPS

February 21, 2013 6:29 AM EST Send to a Friend
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $218 thousand versus the consensus estimate of $370 thousand.

For earnings history and earnings-related data on Lexicon Pharmaceuticals (LXRX) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment